A slide presentation for investors has also been posted on the Company’s website at investor.cencora.com. Participating in the conference call will be: Robert P. Mauch, President & Chief ...

Reconciliations of these measures to GAAP are provided in today’s press release, which is available on our website at investor.cencora.com. We’ve also posted a slide presentation to accompany ...

Reconciliations of these measures to GAAP are provided in today's press release, which is available on our website at investor.cencora.com. We have also posted a slide presentation to accompany ...

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments.

Cencora (COR) has significantly expanded the number and type of medications available in its sure supply program, a drug shortage mitigation initiative designed to provide health systems with ...

Cencora has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings in the amount of approximately $50 million in concurrence with Walgreens Boots Alliance’s sale ...

Baird raised the firm’s price target on Cencora (COR) to $307 from $305 and keeps an Outperform rating on the shares. The firm noted it was another beat and raise quarter. Published first on ...